Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UMSCs for Retinitis Pigmentosa
NCT04763369Phase 2Unknown
- Sponsor
- Jinnah Burn and Reconstructive Surgery Centre
- Start
- Feb 2021
- Primary completion
- May 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in retinitis pigmentosa (RP), sponsored by Jinnah Burn and Reconstructive Surgery Centre. Status: unknown.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
retinitis pigmentosa (RP)
Beyond the preview
Go deeper on NCT04763369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04763369.